Zantac logo

Zantac

A Canada-wide class action alleges Zantac makers concealed cancer risks linked to ranitidine, seeking refunds and damages.

Opening soonOntario, QuebecClaim deadline: Pending court decisionEstimated payout: Compensation pendingClaims not open yet

About this settlement

The case concerns undisclosed cancer risks from ranitidine in Zantac products sold in Canada, with claims that manufacturers failed to warn consumers.

This class action targets manufacturers of Zantac and ranitidine generics for allegedly hiding cancer risks from consumers in Canada. The lawsuit seeks refunds, punitive damages, and other relief for those who purchased or ingested Zantac, which metabolizes into a probable carcinogen called NDMA.

Who qualifies

  • Anyone in Canada who purchased or ingested Zantac or ranitidine products.
  • Includes both over-the-counter and prescription ranitidine users.
  • Residents of Canada, including Quebec and Ontario.

Compensation pending

Claim deadline: Pending court decision

Related settlements

Estée Lauder logo

Estée Lauder

No proof required

Up to $5,000

Claims opening soon

Keurig logo

Keurig

No proof required

Up to $50

5 days left

🔥 534 started this claim

Silk and Great Value logo

Silk and Great Value

Proof required

Up to $300,000

105 days left

Audible logo

Audible

No proof required

Compensation pending

Claims opening soon

Government of Canada logo

Government of Canada

Proof required

Up to $200,000

755 days left

Meta (Facebook) logo

Meta (Facebook)

No proof required

Up to $90

Claims opening soon